Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jun 14, 2021 11:18pm
121 Views
Post# 33386597

RE:Delta Variant

RE:Delta Variant

99942Apophis wrote: I am by far no expert! However this Delta Variant appears to me as the deadliest so if a biopharmaceutical company could prove their vaccine would be highly effective against this and any other possible variants it would make world news instantly. Perhaps during the AGM someone could pose this question if Theralase Covid-19 vaccine would be able to protect against this latest Variant to emerge or even against ones still to emerge! Any thoughts on this would be appreciated, thanks.

 

Hi Apophis....good question, but it's too early to postulate about vaccine potential at this early stage. However, in using TLD-1433 +/- PDT as a therapeutic, one can more clearly see potential based on Dr. Coombs' preclinical work.  I hope TLT eventually pursues this further.  

As for the Delta variant, a recent study from Public Health England showed that the Pfizer vaccine was 88% effective in preventing symptomatic disease due to Delta...not bad at all considering the influenza vaccine is typically 40-50% effective.  The RNA technology used in making the Pfizer vaccine appears to provide a big edge.

<< Previous
Bullboard Posts
Next >>